Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance PankoMab-GEX after chemotherapy in recurrent epithelial ovarian carcinoma
2013-000931-28Phase 2Completed
- Sponsor
- Glycotope
- Start
- Apr 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in epithelial ovarian cancer (EOC) comparing PankoMab-GEX maintenance with Placebo maintenance (2 arms). Started Apr 2013; status: completed.
02
Drugs
Gatipotuzumab
03
Conditions
epithelial ovarian cancer (EOC)
Beyond the preview
Go deeper on 2013-000931-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000931-28.